Francesca Jackson-Spence

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Ejection Fraction

Muscle Invasive Bladder Cancer

Top Venues

Future oncology (London, England)

BJU international

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Jackson-Spence, Matthew Young, Christopher Sweeney, Thomas Powles
Top advances of the year: Genitourinary cancer. Cancer (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Bernadett Szabados, Charlotte Toms, Yu-Hsuen Yang, Christopher Sng, Thomas Powles
Avelumab in locally advanced or metastatic urothelial carcinoma. Expert review of anticancer therapy 22 (2) (2022)
Mehran Afshar, Henry Goodfellow, Francesca Jackson-Spence, Felicity Evison, John Parkin, Richard T Bryan, Helen Parsons, Nicholas D James, Prashant Patel
Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation. BJU international 121 (2) (2017)